Superoxide released from neutrophils causes a reduction in nitric oxide gas
Departments of Medicine and Physiology and Biophysics, Overton Brooks Veterans Affairs and Louisiana State University Medical Centers, Shreveport, Louisiana 71101 Exhaled nitric oxide (NO) is increased in some inflammatory airway disorders but not in others such as cystic fibrosis and acute respirat...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Lung cellular and molecular physiology 1998-12, Vol.275 (6), p.1120-L1126 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Departments of Medicine and Physiology and Biophysics, Overton
Brooks Veterans Affairs and Louisiana State University Medical
Centers, Shreveport, Louisiana 71101
Exhaled nitric oxide (NO) is increased in some
inflammatory airway disorders but not in others such as cystic fibrosis
and acute respiratory distress syndrome. NO can combine
with superoxide (O 2 ) to form
peroxynitrite, which can decompose into nitrate. Activated
polymorphonuclear neutrophils (PMNs) releasing O 2 could account for a reduction in
exhaled NO in disorders such as cystic fibrosis. To test this
hypothesis in vitro, we stimulated confluent cultures of LA-4 cells, a
murine lung epithelial cell line, to produce NO. Subsequently, human PMNs stimulated to produce O 2 were
added to the LA-4 cells. A gradual increase in NO in the headspace
above the cultures was observed and was markedly reduced by the
addition of PMNs. An increase in nitrate in the culture supernatant
fluids was measured, but no increase in nitrite was
detected. Superoxide dismutase attenuated the PMN effect,
and xanthine/xanthine oxidase reproduced the effect. No changes in
epithelial cell inducible NO synthase protein or mRNA were observed.
These data demonstrate that O 2
released from PMNs can decrease NO by conversion to nitrate and suggest
a potential mechanism for modulation of NO levels in vivo.
oxidants; oxygen radicals; nitrogen oxides; cystic fibrosis; lung
disease |
---|---|
ISSN: | 1040-0605 0002-9513 1522-1504 |
DOI: | 10.1152/ajplung.1998.275.6.l1120 |